Titel: ADMET for Medicinal Chemists
Autoren/Herausgeber: Katya Tsaioun, Steven A. Kates (Hrsg.)
Ausgabe: 1. Auflage
KATYA TSAIOUN, PhD, is Chief Scientific Officer of Cyprotexand, previously, president and founder Apredica, which was acquiredby Cyprotex. Both companies specialize in the rapid preclinical invitro assessment of the ADME-Tox (Absorption, Distribution,Metabolism, Elimination, and Toxicity) properties of small-moleculeand peptide therapeutics.
STEVEN A. KATES, PhD is Vice President of Research andDevelopment at Ischemix. He is a highly experienced chemist withover twenty years in R&D for both life science products andhuman therapeutics, and has advanced several compounds through drugdevelopment from early preclinical to early clinical development.He has more than 100 patents and publications, including onebook.